Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Showing results (131-140 of 418) with videos related to

Pageof 42
Sort By:
Journal of the American Academy of Dermatology|October 17, 2017
A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitisSherry H Yu, Aaron M Drucker, Mark Lebwohl, et al.
Journal of Psoriasis and Psoriatic Arthritis|October 27, 2025
Real-world Evidence of Brodalumab Safety for the Treatment of PsoriasisMark Lebwohl, Eingun James Song, Tina Bhutani, et al.
International Journal of Dermatology|May 2, 2026
Real-World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid AntigensKateryna Karpoff, Anya Patel, Georgina Erfe, et al.
Journal of the American Academy of Dermatology|June 9, 2019
Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator-controlled phase 3 AMAGINE-2 trialLuis Puig, Mark Lebwohl, Hervé Bachelez, et al.
Journal of the American Academy of Dermatology|November 26, 2003
Daily UVB exposure levels in high-school students measured with digital dosimetersEthan G Rigel, Mark Lebwohl, Adam C Rigel, et al.
Dermatologic Clinics|April 20, 2005
The use of systemic immune moderators in dermatology: an updateDana Kazlow Stern, Jackie M Tripp, Vincent C Ho, et al.
Journal of the American Academy of Dermatology|April 7, 2009
Treatments for psoriasis and the risk of malignancyRita V Patel, Lily N Clark, Mark Lebwohl, et al.
Clinical, Cosmetic and Investigational Dermatology|September 8, 2016
Relationship between severity of the local skin reactions and the rate of local skin reaction resolution in patients treated with ingenol mebutate gelShelbi C Jim On, Kim Mark Knudsen, Torsten Skov, et al.
Toxicology and Applied Pharmacology|April 15, 2003
Synergistic enhancement of H2O2 production in human epidermoid carcinoma cells by Benzo[a]pyrene and ultraviolet A radiationEileen Q Shyong, Yuhun Lu, Amy Goldstein, et al.
Journal of the American Academy of Dermatology|November 26, 2009
Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus ConferenceDavid M Rosmarin, Mark Lebwohl, Boni E Elewski, et al.
Pageof 42

Showing results (131-140 of 418) with videos related to

Sort By:
Pageof 42
Journal of the American Academy of Dermatology|October 17, 2017
A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitisSherry H Yu, Aaron M Drucker, Mark Lebwohl, et al.
Journal of Psoriasis and Psoriatic Arthritis|October 27, 2025
Real-world Evidence of Brodalumab Safety for the Treatment of PsoriasisMark Lebwohl, Eingun James Song, Tina Bhutani, et al.
International Journal of Dermatology|May 2, 2026
Real-World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid AntigensKateryna Karpoff, Anya Patel, Georgina Erfe, et al.
Journal of the American Academy of Dermatology|June 9, 2019
Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator-controlled phase 3 AMAGINE-2 trialLuis Puig, Mark Lebwohl, Hervé Bachelez, et al.
Journal of the American Academy of Dermatology|November 26, 2003
Daily UVB exposure levels in high-school students measured with digital dosimetersEthan G Rigel, Mark Lebwohl, Adam C Rigel, et al.
Dermatologic Clinics|April 20, 2005
The use of systemic immune moderators in dermatology: an updateDana Kazlow Stern, Jackie M Tripp, Vincent C Ho, et al.
Journal of the American Academy of Dermatology|April 7, 2009
Treatments for psoriasis and the risk of malignancyRita V Patel, Lily N Clark, Mark Lebwohl, et al.
Clinical, Cosmetic and Investigational Dermatology|September 8, 2016
Relationship between severity of the local skin reactions and the rate of local skin reaction resolution in patients treated with ingenol mebutate gelShelbi C Jim On, Kim Mark Knudsen, Torsten Skov, et al.
Toxicology and Applied Pharmacology|April 15, 2003
Synergistic enhancement of H2O2 production in human epidermoid carcinoma cells by Benzo[a]pyrene and ultraviolet A radiationEileen Q Shyong, Yuhun Lu, Amy Goldstein, et al.
Journal of the American Academy of Dermatology|November 26, 2009
Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus ConferenceDavid M Rosmarin, Mark Lebwohl, Boni E Elewski, et al.
Pageof 42